Navigation Links
Bond Laboratories Selects Wasserman Media Group
Date:11/28/2007


Global Sports and Entertainment Company to Market Fusion(TM) Instant Energy

Brands SOLANA BEACH, Calif. and CARLSBAD, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Bond Laboratories, Inc. (OTC Bulletin Board: BNDB), a manufacturer of Fusion(TM) Blast and Fusion(TM) Shots nutritional energy products, has appointed Wasserman Media Group (WMG), to manage global marketing opportunities for its entire line of Fusion(TM) Instant Energy products. Through the agreement, WMG will work to partner Fusion(TM) with appropriate high profile athletes, promotions and feature Fusion(TM) at select large-scale events.

Eric Schick, President of Bond Laboratories, commented, "This partnership represents a vital step in the growth and development and of the Fusion(TM) brand nationally. WMG has a proven track record of consulting, endorsement and sponsorship programs for prominent sports and entertainment properties as well as consumer brands. Aligning ourselves with a company as dynamic as WMG will bring all Fusion(TM) products high visibility within the sports and entertainment event sectors."

Steve Astephen, Principal of Action Sports at WMG stated, "We are excited to be working with a company who embraces what sports and entertainment can do for their brand. We look forward to putting together cutting-edge programs that will help to elevate their brand to the next level."

About Bond Laboratories:

Bond Laboratories is a premier marketer and manufacturer of nationally branded nutritional products. Bond has brought together a seasoned team of highly successful sales and marketing executives with considerable experience in the launch and development of many well known branded products. With our previous nutraceutical and pharmaceutical sales and management expertise, Bond Laboratories, Inc. is currently focused on developing proprietary products, as well as delivery platforms, that address the needs and concerns of today's consumer. For more information on Fusion(TM) Products, interested persons can go to http://www.got-fusion.com.

About Wasserman Media Group

Wasserman Media Group (WMG) is a worldwide leader in sports management, marketing and content. WMG is also the holding company for the Los Angeles Avengers of the Arena Football League. More information about WMG and its businesses is available at http://www.wmgllc.com.

Wasserman Media Group, LLC (http://www.wmgllc.com) is also a leading global sports and Entertainment Company, and its Management, Marketing and Content divisions collectively represent the industries' most recognized athletes and brands. As the number one sports talent agency in basketball, baseball, soccer and action sports, WMG Management represents over 400 clients throughout the world. Recognized as the foremost naming rights expert, WMG Marketing also handles consulting, endorsement and sponsorship programs for the world's most prominent sports and entertainment properties and consumer brands.

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward- looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact: Scott Landow Phone: 858.847.9000

sdlandow@bond-labs.com Fax: 858.847.9090


'/>"/>
SOURCE Bond Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF Orthopaedic Center ... Houston Area. The new location is located at 2255 E. Mossy Oaks Rd., Suite ... This newest location will provide patients living in the north Houston area (The Woodlands, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy ... 960 Gruene Road in Building 2. The clinic is the group’s second in New ... says opening the company’s second New Braunfels location brings things full circle for the ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The IoT ... and WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... estimates the IoT will have a value anywhere from $4 trillion to $11 trillion ...
(Date:3/23/2017)... ... ... of adults are unaware of the dangers that infectious bacteria play in mouth disease, while ... a day that dentists recommend. The ramifications of improper oral upkeep go far beyond bad ... 164 million hours of work each year due to dental issues. That is why Mediaplanet ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and ... health. Every day, two kidneys filter about 120 to 150 quarts of blood. Put ... waste, regulating fluid levels and blood pressure, supporting bone health and promoting red blood ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the ... Strategies" report to their offering. ... Pain Management in the ... their physical pain, emphasizing consumer survey analysis, including trends over ... adults who have selected illnesses/conditions strongly associated with physical pain ...
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: